The selective serotonin reuptake inhibitor fluvoxamine is used on- and off-label in the treatment of children and adolescents with psychiatric disorders. To investigate the relationship between fluvoxamine dose, serum concentration and clinical outcomes in daily clinical practice, and to validate a therapeutic reference range (TRR) in pediatric patients, multicenter prospective and observational study data were analyzed.
No takes yet. Share an insight, caveat, or question.
Taurines et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: